ReviewBiochemical pharmacology2012

Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Xiangyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.